Imaging has traditionally been used to document what (already) happened. What if it could help determine what happens next?
On the newest episode of Fractals, Colin Miller is joined by Fidēs Imaging CEO Roughan Sheedy and Head of Women’s Health Beth Fisher to discuss how advanced imaging can support earlier, sharper development decisions.
They explore:
Why early-phase programs need more than standardized endpoints
How imaging biology in motion can uncover previously invisible phenomena
Where dynamic imaging may add value across GI disease, women’s health, fibrosis, inflammation, and solid tumors
What it will take for emerging imaging endpoints to earn regulatory credibility
Podden och tillhörande omslagsbild på den här sidan tillhör
The Bracken Group. Innehållet i podden är skapat av The Bracken Group och inte av,
eller tillsammans med, Poddtoppen.
